Cardio-oncology considerations for breast cancer: Risk stratification, monitoring, and treatment Review


Authors: Wallins, J. S.; Diaz Saravia, S.; Bolaji, O.; Shaikh, Z. A.; Yu, A. F.
Review Title: Cardio-oncology considerations for breast cancer: Risk stratification, monitoring, and treatment
Abstract: Long-term outcomes of patients with breast cancer have steadily improved due to advances in early detection and cancer therapeutics. Cardiovascular disease (CVD) is a leading cause of non--cancer-related mortality in this population, and this has been attributed to the cardiovascular toxicity of common breast cancer treatments including chemotherapy and radiation as well as shared risk factors between cancer and CVD. Identifying patients at risk of developing treatment-related cardiotoxicities is crucial to inform clinical decisions regarding surveillance, prevention, and management. In this review, we provide a broad overview of the treatment-related cardiotoxicities associated with common breast cancer treatment. We present data on risk-stratifi cation tools for oncologists, including when to refer to a cardiologist, as well as recommendations for cardiovascular testing tailored to individual treatment regimens. Lastly, we review recent trial data on preventive and therapeutic approaches to treatment-related cardiotoxicities, and future directions that may lead to improved cardiovascular outcomes in this population.
Keywords: disease management; early detection of cancer; disease surveillance; decision making, clinical; cardio-oncology; breast neoplasms diagnosis; breast neoplasms therapy; chemotherapy, cancer adverse effects; cardiotoxicity risk factors; cardiotoxicity prevention and control; cardiotoxicity chemically induced; breast neoplasms radiotherapy
Journal Title: Oncology (Norwalk)
Volume: 39
Issue: 5
ISSN: 0890-9091
Publisher: C M P Medica LLC * The Oncology Group  
Date Published: 2025-06-01
Start Page: 188
End Page: 197
DOI: 10.46883/2025.25921044
PROVIDER: EBSCOhost
PROVIDER: cinahl
PUBMED: 40600749
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PubMed record and PDF -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anthony Yu
    94 Yu
  2. Olayiwola Akeem Bolaji
    13 Bolaji
  3. Zohaib Ali Shaikh
    1 Shaikh